A team bond by a shared vision
MagIA diagnostics has created over 15 jobs since 2017. We are proud to contribute to offer these opportunities in our region. As fast growing company, we constantly recruit new collaborators. You can consult our open job positions here or send us your job application via mail.
The recent achievements would not have been possible without the dedicated and diverse team we have built. We believe that keeping a participative, stimulating and friendly work environment is crucial and make sure each collaborator progress with the project.
The innovative diagnostic technology developed by MagIA is the result of 15 years of collaboration between several research institutes from Grenoble. The patented MagIA innovation, which explores the application to biotechnology of magnetic interactions at the submillimeter scale, has been the subject of several theses which have explored its application to different biological parameters, demonstrated its clinical potential and its industrializable nature.
The team was mentored by a local incubator, the SATT Linksium Grenoble. During this time, the MagIA technology was improved with the help of medical doctors, diagnostic players and pharmaceutical companies in order to offer a real solution to our future customer. In 2017, after two years of incubation, the legal entity MagIA diagnostics was born.
A team working together since the beginning
Paul, our CEO, is in charge of sales and marketing. After a PhD in magnetism applied to biomanipulation in Grenoble, Paul evolved internationally in the US and in France in two start-up companies mainly focused on cell manipulation and innovative high throughput screening solutions. In December 2014, he returned to Grenoble to join our group and launch the start-up.
Finance & Operations
After graduating from ESSEC Business School (Paris), Cédric worked at Banque Paribas in France and in New York in structured finance transactions. In 1999, he joined the European private equity investor, Argos Soditic, where he spent 17 years (inc.10 years as partner) leading investments in France and in Switzerland. Cédric joined MagIA diagnostics in 2017 as CFO and COO.
Research & Development
Sarah, the biologist of the team was trained in in vitro diagnostics. In 2013, she developed a biomolecular test for infectious diseases at the Institut Pasteur (Madagascar). During her PhD (IAB and G2ELab), she developed the protocol which is now used in the MagIA immunoassay. Since 2017, she is in charge of the Research & Development (RD) efforts and Regulatory Affairs (RA).
Mario joined the MagIA diagnostics team in spring 2015 as a masters student. He is a mechanical and process engineer by training and possesses strong skills in microfluidics. During his PhD, he worked on the micromagnetic structures as well as the microfluidic cartridge concept. Since 2018, he is in charge of the industrialization and production of the cartridge at MagIA diagnostics.
MD, PharmD, is the founder of several biotechnology companies based on the development of antiviral drugs (ACTgene & Genoscience Pharma). He is the head of the internal medicine department of the European Hospital of Marseille. He is also in charge of the R&D at Marseille Central Labs AlphaBio.
is the former CEO of MacoPharma. He is bringing to MagIA diagnostics his strong knowledge in the Medical Device industrial field, as well as his network among financial investors.
is representant of WICAP MagIA shareholders.He is currently Supply Chain Programs Coordinator in a medical device company leader in his business. He has a strong and diversified experience in Planning, Manufacturing, New Product Introduction, Procurement and implementation of information system
Medical & health care